Rare diseases
Investigational molecules
Locations
17 Briden Street Office 329, 01605-2662, United States
Leal Therapeutics Inc. focuses its clinical research on amyotrophic lateral sclerosis, with attention to disease areas affecting motor neuron function and progressive muscle weakness. Its trial activity is centered on adult participants living with ALS.
The sponsor’s research activity in this area is directed toward identifying treatments relevant to the neurological decline associated with ALS.
Leal Therapeutics Inc. runs clinical trials in conditions such as Amyotrophic lateral sclerosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
